ArticleCureus2025
Urgent Myectomy for Hemodynamic Instability: Leveraging the Advantages of a Perceval Sutureless Valve for Unexpected Systolic Anterior Motion After Declamping the Aorta.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Forward Dynamics: Modern Insights into Mitral Systolic Anterior Motion.Journal of cardiovascular development and disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sutureless aortic valve replacement (AVR) has been widely recognized for its ability to reduce aortic cross-clamp and cardiopulmonary bypass times while allowing for intraoperative repositioning or reimplantation. However, unexpected complications such as systolic anterior motion (SAM) can arise, necessitating additional surgical interventions. We report the case of a 61-year-old male with a history of hypertension and Behçet's disease in his youth, which had remained clinically inactive. He presented with worsening dyspnea, and preoperative echocardiography revealed moderate aortic stenosis with a bicuspid aortic valve and moderate mitral regurgitation secondary to chordal rupture. Although the patient did not strictly meet the criteria for SAM risk, he had a mildly hypertrophied interventricular septum measuring 13 mm. The patient underwent concomitant mitral valve repair and sutureless AVR using a Perceval valve. Following aortic declamping, intraoperative transesophageal echocardiography revealed severe SAM and left ventricular outflow tract obstruction with worsening mitral regurgitation. Notably, septal hypertrophy was more pronounced intraoperatively, and the left ventricular morphology was determined to be a significant contributing factor to SAM. Given the hemodynamic instability, a myectomy was performed through the aortic valve approach. The sutureless Perceval valve was easily removed and reimplanted, allowing for rapid completion of the procedure without excessive prolongation of myocardial ischemia. Compared to a standard bioprosthesis, the ease of valve removal and repositioning provided a crucial advantage in this setting, facilitating prompt surgical intervention. Postoperatively, the patient recovered well, with no residual SAM or mitral regurgitation on follow-up echocardiography. This case highlights the utility of sutureless AVR in complex cardiac surgery, particularly in scenarios requiring additional intraoperative interventions. The ability to promptly remove and reposition the valve enabled effective management of SAM while minimizing ischemic time, underscoring its advantage over conventional bioprosthetic valves in such situations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.